2025-04-10 - Analysis Report
## IONQ Inc. (IONQ) Stock Report

**0. Key Figures:**

* **Cumulative Return (IONQ):** 193.81%
* **Cumulative Return (VOO/S&P 500):** 13.19%
* **Return Difference (IONQ - VOO):** 180.6%
* **Relative Divergence:** 66.0% (Indicates IONQ's performance is significantly higher than VOO, relative to its historical range of divergence.)
* **Current Closing Price:** $26.37


**1. Company Overview and Performance Analysis:**

IONQ Inc. is a quantum computing company.  The provided data shows IONQ significantly outperformed the S&P 500 (VOO) over the analysed period.  While the cumulative return for IONQ is substantially higher (193.81% vs 13.19%), the relative divergence metric (66%)  indicates that while currently high, this outperformance is within the historical range of the stock's performance relative to the S&P 500.  The Alpha and Beta values vary significantly across the provided periods, suggesting volatility in the stock's performance and correlation to the market.  High Beta values (above 1) imply higher volatility than the market.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2021-2023  | 93.0% | 72.8% | 73.0% | 0.2 | 3.0 |
| 2022-2024  | 199.0% | 72.8% | 180.0% | 0.0 | 10.0 |
| 2023-2025  | 195.0% | 67.0% | 184.0% | 0.4 | 6.3 |

**2. Recent Price Movement:**

* **Closing Price:** $26.37
* **5-Day Moving Average:** $22.87
* **20-Day Moving Average:** $23.41
* **60-Day Moving Average:** $30.41

The price is currently below its 60-day moving average, indicating a potential downward trend.  The significant difference between the closing price and the 60-day average ($4.04) also points to a recent drop.  The recent price change of 23.92% (from $21.28) is a significant upward jump.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.53 (High Risk)
* **RSI:** 60.46 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 1.89 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** +5.9 (Short-term upward trend)
* **Expected Return:** 25.3% (Long-term, exceeding S&P 500)


The high MRI suggests significant risk associated with the stock.  The positive PPO and upward trending relative divergence signal positive short-term momentum.  The substantial recent price increase (23.92%) indicates a potential rapid price surge which can be associated with high volatility. The 25.3% expected return is promising for long-term investors, exceeding the expected S&P 500 return.

**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2024-11-06 | -$0.24 | $0.01B      |
| 2024-08-07 | -$0.18 | $0.01B      |
| 2024-05-10 | -$0.19 | $0.01B      |
| 2023-11-09 | -$0.22 | $0.01B      |
| 2024-11-06 | -$0.22 | $0.01B      |

The company is currently reporting negative EPS, indicating consistent losses. Revenue remains relatively flat at $0.01B. This suggests that while the stock price shows high growth, the underlying financial performance needs close attention.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.01B | 56.92%      |
| 2024-09-30 | $0.01B | 47.46%      |
| 2024-06-30 | $0.01B | 50.59%      |
| 2024-03-31 | $0.01B | 54.97%      |
| 2023-12-31 | $0.01B | 48.20%      |

**Capital and Profitability:**

| Quarter | Equity | ROE       |
|---------|---------|-----------|
| 2024-12-31 | $0.38B | -52.62%   |
| 2024-09-30 | $0.44B | -12.05%   |
| 2024-06-30 | $0.46B | -8.11%    |
| 2024-03-31 | $0.48B | -8.25%    |
| 2023-12-31 | $0.48B | -8.64%    |

Profit margins are relatively healthy, but the negative ROE indicates the company is not generating returns on its equity.  This is a significant concern and needs further investigation.


**6. Overall Analysis:**

IONQ has shown exceptionally high returns compared to the S&P 500, but this needs to be viewed in context of the underlying financial performance.  While the stock price shows significant upward momentum, the company is currently unprofitable, with negative EPS and ROE.  The high risk indicated by the MRI and volatile Beta values highlight the significant risk involved in investing in this company.  Long-term investors might be attracted by the high expected return but must carefully consider the financial risks inherent in a company that is yet to demonstrate profitability.  Further research into the company's future prospects and technological advancements is crucial before making any investment decisions.  The recent price surge warrants caution, as it might not be fully justified by the company's current financial situation.
